stockmarketproxy
/
EXELNasdaq SEC EDGAR

EXELIXIS, INC.

Biological Products, (No Diagnostic Substances)·ALAMEDA, CA·FY end 01/01·CIK 939767
OverviewFinancialsCompensationGovernanceInsidersFilings
CEO Pay Ratio
81:1
Dr. Morrissey
CEO Total Comp
$33.2M
Dr. Morrissey
Median Employee
$410,693
Revenue
$2.3B
FY 2025
Net Income
$782.6M
FY 2025
Free Cash Flow
$875.8M
FY 2025
Net Margin
33.7%
Insider Net (180d)
-$22.5M
1 buys / 18 sales

CEO Pay Accountability

CEO comp as % of net income
4.25%
For every $1,000 of profit, $42.47 flows to the CEO.
CEO comp as % of buybacks
3.51%
CEO comp equals 35.1‰ of cash returned to shareholders via buybacks.

Financials

5-year history · USD
MetricFY 2025FY 2024FY 2023FY 2022FY 2021Trend
Revenue$2.3B$2.2B$1.8B$1.6B$1.4B
Gross Profit
Operating Income$872.2M$604.6M$170.9M$201.5M$286.7M
Net Income$782.6M$521.3M$207.8M$182.3M$231.1M
Operating CF$884.3M$700.0M$333.3M$362.6M$400.8M
Capex$8.4M$28.4M$40.5M$27.7M$64.2M
Free Cash Flow$875.8M$671.5M$292.9M$334.9M$336.6M
Buybacks$947.5M$652.0M$550.4M
Dividends
Gross Margin
Operating Margin37.6%27.9%9.3%12.5%20.0%
Net Margin33.7%24.0%11.4%11.3%16.1%
FCF Margin37.7%31.0%16.0%20.8%23.5%
R&D / Revenue35.6%42.0%57.0%55.4%48.3%
Effective Tax
Debt / Equity
Buybacks / FCF108.2%97.1%187.9%

Named Executive Officers

FY 2025
ExecutiveSalaryStockOptionsBonus / Inc.OtherTotal
Dr. Morrissey · CEO
$33.2M
Michael M. MorrisseyPh.D.
$1.3M$30.5M$1.4M$11.0K$33.2M
Amy C. PetersonM.D.
$614.5K$8.4M$2.1M$11.1M
Christopher J. SennerExecutive Vice President
$822.8K$9.3M$470.8K$11.0K$10.6M
Dana T. AftabPh.D.
$659.1K$9.5M$397.3K$11.0K$10.5M
Jeffrey J. HessekielJ.D.
$672.4K$8.3M$11.0K$9.0M
Research and Development
$577.9K$4.8M$294.1K$11.0K$5.7M
Brenda J. HeftiJ.D., Ph.D. Senior Vice President and General Counsel
$454.5K$3.5M$286.8K$11.0K$4.2M
Dr. Hefti
Dr. Aftab
Mr. Haley
Dr. Peterson
Mr. Senner
Patrick J. HaleyExecutive Vice President, Commercial
$621.3K$8.1M$327.3K$11.0K$9.0M
Mr. Hessekiel